{
  "id": 15902954,
  "title": "Roivant's autoimmune drug succeeds in two pivotal trials, setting up 2027 filing",
  "url": "https://urgent.news/2026/10/21/roivants-autoimmune-drug-succeeds-in-two-pivotal-trials-setting-up",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-21T14:39:09.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/roivants-autoimmune-drug-succeeds-in-two-pivotal-trials-setting-up-2027-filing/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Roivant Sciences on Wednesday checked off another milestone in its attempt to build a franchise drug in autoimmune diseases. The biotech said two trials for brepocitinib, which won its first approval earlier ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}